Sign in if you already have an account.
  
donate.gif

Affiliate News

Hispanic/Latino Leaders Trained to be Breast Health Advisors
The Moore/Lee Amando la Vida/Loving Life Initiative gathered Hispanic/Latina leaders in Robbins to provide scientifically based breast health community adviser training. Thursday's training program was the result of a capacity-building grant awarded to the twin county initiative by the Susan G. Komen North Carolina Triangle to the Coast Affiliate..
More

Raleigh Runners plan 132-mile Relay to Inaugural Wilmington Race for the Cure®
The 132-mile route begins in Raleigh at the offices of Susan G. Komen for the Cure® North Carolina Triangle to the Coast Affiliate at 133 Fayetteville Street and ends in Wilmington at the intersection of 2nd and Market Street. .
More

Grant ‘Passes the Promise’ of the Race for the Cure® to Wilmington
Nine community health organizations have been awarded the “Passing the Promise” grant to aid their participation in the March 2nd Inaugural Wilmington Race for the Cure®. .
More

more
Affiliate Monthly
Why should I support Komen North Carolina Triangle to the Coast?


• 75% of net funds are invested locally to fund education, screening and treatment programs.


• 25% of net funds are dedicated to research and finding the cure(s) for breast cancer.


• Last year, with the help of our supporters, more than 40,000 North Carolinians were directly impacted by Komen North Carolina Triangle to the Coast community health grants.


Every 69 seconds a life is lost to breast cancer. Your gift may save a life.

Donate Today
more
National Spotlight

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

Life after breast cancer booklet

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.

Researchers conducting clinical trials
more